Sign in

What researchers published on Liver cirrhosis

40,153 papers, newest first.

Showing 20 of 40,153

  • ReviewThe potential benefit of sodium glucose cotransporter (SGLT)-2 inhibitors in liver cirrhosis: A mini review.Therapeutic advances in gastroenterology
  • ReviewBiomarkers to assess early signs of fibro-inflammatory disease modification following short-term therapeutic intervention in people living with MASLD/MASH: A systematic scoping review.PloS one
  • The Clinical Value of D-D, AT-Ⅲ, NLR, PLT and ALB Measurement in Liver Diseases.Clinical laboratory
  • Predicting Cirrhotic Patients' Transition From Compensated to Decompensated Stage: A Graph-Based Multitask Deep Learning Method.JMIR medical informatics
  • Reply to Letter to the Editor on Beyond Prophylaxis: Antimicrobial Stewardship for Bacterial Infections in Cirrhosis.United European gastroenterology journal
  • Genes That Reliably Differentiate Liver-Fibrosis Stages Identified Using a Novel Integrated Statistical and Machine-Learning Algorithm.Genetic epidemiology
  • Regulatory T-Cell Dynamics During and After Direct Acting Antivirals in Cirrhotic HCV Genotype 4 Patients.Journal of viral hepatitis
  • Development and internal validation of VA-BLED for 1-year esophageal variceal bleeding risk in cirrhosis.PloS one
  • ReviewHepatic metabolic plasticity: From physiological adaptation to energy overload-associated pathological progression and therapeutic targeting.Journal of physiology and biochemistry
  • Integrative transcriptomic and single-nucleus analyses identify microbiota-metabolite-associated immune signatures of fibrosis severity in MASLD.PloS one
  • Two-dimensional speckle-tracking imaging for assessing cardiac dysfunction in liver cirrhosis: correlation with Child-Pugh score.Cardiovascular ultrasound
  • Review[Screening, diagnosis, treatment, and follow-up of hepatitis C virus-related liver disease].Orvosi hetilap
  • Inflammatory bowel disease increases the risk of liver cirrhosis: a retrospective population-based study.Sage open chronic disease
  • PRPF19 drives hepatic stellate cell activation and liver fibrosis via PKM2-mediated glycolytic reprogramming.Nature communications
  • Clinical characteristics and prognostic factors of ascitic fungal infections in patients with cirrhosis.Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
  • Anthropometric measurements, nutritional status, and diet quality of cirrhosis patients: Comparison of two etiologies.Hepatology forum
  • Associations of Myosteatosis with Osteoporosis, Vertebral Fractures, and Long-Term Prognosis in Patients with Cirrhosis.Journal of clinical medicine
  • Transcriptome Analysis Reveals the Role of Partial Lymphatic Vessel Ligation in Rats with Cirrhotic Portal Hypertension.Cells
  • Interassay and interlaboratory comparison of von Willebrand factor antigen as a diagnostic and prognostic biomarker in advanced chronic liver disease.Research and practice in thrombosis and haemostasis
  • Metabolomic Differences Between Wild and Cultivated Ophiocordyceps sinensis Identify Source-Associated Metabolites with Predicted Antifibrotic Relevance.International journal of molecular sciences